For the complete label, including companion diagnostic indications and complete risk information, please visit . Order and interpret diagnostic tests, such as x rays or blood tests Diagnose a. Patients who are negative for other companion diagnostic mutations should be reflexed to tumor tissue testing and mutation status confirmed using an FDA-approved tumor tissue test, if feasible. Uncover why Inform Diagnostics is the best company for you. Compare pay for popular roles and read about the team’s work-life balance. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Inform Diagnostics Careers and Employment. When considering eligibility for certain therapies for which FoundationOne Liquid CDx is a companion diagnostic, testing of plasma is only appropriate where tumor tissue is not available. Find out what works well at Inform Diagnostics from the people who know best. Find out what works well at Inform Diagnostics from the people who know best. The average Inform Diagnostics hourly pay ranges from approximately 18 per hour for a Lab Aide to 38 per hour for a Histotechnologist. The information contained on this site should not be used as a substitute.

A negative result does not rule out the presence of an alteration. The average Inform Diagnostics salary ranges from approximately 37,571 per year for a Lab Aide to 260,042 per year for a Sales Director. Careers Contact Us For Physicians Physician Portal Integrate With Us Order. Use of the test does not guarantee a patient will be matched to a treatment. The estimated additional pay is 8,164 per year. The estimated base pay is 66,528 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. information on this site is subject to the terms of our Legal Notice. The estimated total pay for a Revenue Analyst at Inform Diagnostics is 74,692 per year. Additional genomic findings may be reported and are not prescriptive or conclusive for labeled use of any specific therapeutic product. Careers Privacy Policy About J&J Media Center Cookie Policy Legal Notice. The test analyzes 324 genes utilizing circulating cell-free DNA and is FDA-approved to report short variants in 311 genes and as a companion diagnostic to identify patients who may benefit from treatment with specific therapies (listed in Table 1 of the Intended Use) in accordance with the approved therapeutic product labeling. FoundationOne®Liquid CDx is for prescription use only and is a qualitative next-generation sequencing based in vitro diagnostic test for advanced cancer patients with solid tumors.

Inform diagnostics careers